Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Melanoma and CD4[original query] |
---|
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma. Journal of medical genetics 2015 Apr 52 (4): 231-9. Rendleman Justin, Vogelsang Matjaz, Bapodra Anuj, Adaniel Christina, Silva Ines, Moogk Duane, Martinez Carlos N, Fleming Nathaniel, Shields Jerry, Shapiro Richard, Berman Russell, Pavlick Anna, Polsky David, Shao Yongzhao, Osman Iman, Krogsgaard Michelle, Kirchhoff Tom |
Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma. Molecules (Basel, Switzerland) 2019 7 24 (13): . Petralia Maria Cristina, Mazzon Emanuela, Fagone Paolo, Russo Andrea, Longo Antonio, Avitabile Teresio, Nicoletti Ferdinando, Reibaldi Michele, Basile Maria Sof |
Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients. Nature medicine 2019 6 25 (6): 929-935. Sullivan Ryan J, Hamid Omid, Gonzalez Rene, Infante Jeffrey R, Patel Manish R, Hodi F Stephen, Lewis Karl D, Tawbi Hussein A, Hernandez Genevive, Wongchenko Matthew J, Chang YiMeng, Roberts Louise, Ballinger Marcus, Yan Yibing, Cha Edward, Hwu Patri |
Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 6 14 (10): 1807-1817. Chae Young Kwang, Viveiros Pedro, Lopes Gilberto, Sukhadia Bhoomika, Sheikh Muhammad Mubbashir, Saravia Diana, Florou Vaia, Sokol Ethan S, Frampton Garrett M, Chalmers Zachary R, Ali Siraj M, Ross Jeffrey S, Chang Sangmin, Wang Si, Chiec Lauren, Rahbari Ashkon, Mohindra Nisha, Villaflor Victoria, Shin Sang Ha, Oh Michael, Anker Jonathan, Park Lee Chun, Wang Victor, Chuang Jeffrey, Park Wung |
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 5 25 (16): 5061-5068. Hu-Lieskovan Siwen, Lisberg Aaron, Zaretsky Jesse M, Grogan Tristan R, Rizvi Hira, Wells Daniel K, Carroll James, Cummings Amy, Madrigal John, Jones Benjamin, Gukasyan Jacklin, Shintaku I Peter, Slamon Dennis, Dubinett Steven, Goldman Jonathan W, Elashoff David, Hellmann Matthew D, Ribas Antoni, Garon Edward |
BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis. Pathology, research and practice 2019 Sep 152671. Min Kyueng-Whan, Choe Ji-Young, Kwon Mi Jung, Lee Hye Kyung, Kang Ho Suk, Nam Eun Sook, Cho Seong Jin, Park Hye-Rim, Min Soo Kee, Seo Jinwon, Kim Yun Joong, Kim Nan Young, Kim Ho You |
TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti-CTLA4 treatment. Cancer medicine 2020 Aug . Li Huahua, Li Jia, Zhang Chenyue, Zhang Chenxing, Wang Haiyo |
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature 2020 7 585 (7823): 107-112. Sahin Ugur, Oehm Petra, Derhovanessian Evelyna, Jabulowsky Robert A, Vormehr Mathias, Gold Maike, Maurus Daniel, Schwarck-Kokarakis Doreen, Kuhn Andreas N, Omokoko Tana, Kranz Lena M, Diken Mustafa, Kreiter Sebastian, Haas Heinrich, Attig Sebastian, Rae Richard, Cuk Katarina, Kemmer-Brück Alexandra, Breitkreuz Andrea, Tolliver Claudia, Caspar Janina, Quinkhardt Juliane, Hebich Lisa, Stein Malte, Hohberger Alexander, Vogler Isabel, Liebig Inga, Renken Stephanie, Sikorski Julian, Leierer Melanie, Müller Verena, Mitzel-Rink Heidrun, Miederer Matthias, Huber Christoph, Grabbe Stephan, Utikal Jochen, Pinter Andreas, Kaufmann Roland, Hassel Jessica C, Loquai Carmen, Türeci Özl |
Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. PloS one 2020 10 15 (10): e0240331. Meng Liangliang, He Xiaoxi, Zhang Xiao, Zhang Xiaobo, Wei Yingtian, Wu Bin, Li Wei, Li Jing, Xiao Yueyo |
Prognostic value and immunological role of PDCD1 gene in pan-cancer. International immunopharmacology 2020 Oct 89 (Pt B): 107080. Miao Yandong, Wang Jiangtao, Li Qiutian, Quan Wuxia, Wang Yingying, Li Chen, Wu Jingjing, Mi Dengh |
Differential Expression of the TLR4 Gene in Pan-Cancer and Its Related Mechanism. Frontiers in cell and developmental biology 2021 10 9 700661. Hu Jialing, Xu Jiasheng, Feng Xiaojin, Li Yiran, Hua Fuzhou, Xu Guoh |
HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade. Annals of oncology : official journal of the European Society for Medical Oncology 2022 3 33 (7): 728-738. Shao X M, Huang J, Niknafs N, Balan A, Cherry C, White J, Velculescu V E, Anagnostou V, Karchin |
Effect of MUC16 mutations on tumor mutation burden and its potential prognostic significance for cutaneous melanoma. American journal of translational research 2022 3 14 (2): 849-862. Wang Zi, Hou Huimin, Zhang Haomin, Duan Xingwu, Li Lingling, Meng Lingfe |
Role of Single Nucleotide Polymorphism-Related Genes in Tumour Immune Cell Infiltration and Prognosis of Cutaneous Melanoma. BioMed research international 2023 5 2023 3754094. Baihe Wang, Fanxiao Liu, Yuanyuan Li, Nan Ch |
Antitumor Immune Responses in B2M-Deficient Cancers. Cancer immunology research 2023 10 . Davis Y Torrejon, Mildred Galvez, Gabriel Abril-Rodriguez, Katie M Campbell, Egmidio Medina, Agustin Vega-Crespo, Anusha Kalbasi, Begoña Comin-Anduix, Antoni Rib |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: